Related references
Note: Only part of the references are listed.VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment
Masato Murakami et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Flt-1 signaling in macrophages promotes glioma growth in vivo
Mark Kerber et al.
CANCER RESEARCH (2008)
Anti-VEGF therapy: comparison of current and future agents
D. J. Pieramici et al.
EYE (2008)
VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma
Arindel S. R. Maharaj et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Farbod Shojaei et al.
NATURE (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
Henk. M. W. Verheul et al.
NATURE REVIEWS CANCER (2007)
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Ridgway et al.
NATURE (2006)
Macrophages regulate the angiogenic switch in a mouse model of breast cancer
Elaine Y. Lin et al.
CANCER RESEARCH (2006)
A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model
Hiroaki Ohno et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts
P Paulus et al.
CANCER RESEARCH (2006)
Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants
D Kerjaschki et al.
NATURE MEDICINE (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Retinal angiogenesis in development and disease
RF Gariano et al.
NATURE (2005)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature
IB Lobov et al.
NATURE (2005)
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
P Baluk et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
S Aharinejad et al.
CANCER RESEARCH (2004)
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
H Gerhardt et al.
JOURNAL OF CELL BIOLOGY (2003)
Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis
P Rutkowski et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The pathogenesis of diabetic retinopathy: old concepts and new questions
J Cai et al.
EYE (2002)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
